Lai Wang, Global Head of R&D at BeiGene, Ltd. (BGNE), sold 2,650 shares at $192.42 ($510K) on 2023-06-20, disclosed to the SEC on 2023-06-20.
Open-market sale of $510k BGNE by Global Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $192.42 | 1,325 | $255K | 50.0% |
| 2 | $192.42 | 1,325 | $255K | 50.0% |
| Total | $192.42 avg | 2,650 | $510K | 100% |
| Filing → |
| ONC | SELL | 2026-06-15 | $197K | — | Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |